On November 10, 2022, Dr. Andrew Salzman submitted to Innovation1 Biotech Inc., a notice of resignation from his position as Chief Science Officer of the Company, with such resignation to be effective immediately. The Company accepted the resignation of Dr. Salzman on November 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | -.--% | -99.07% |
01-17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+210.80% | 6.73B | |
+9.53% | 1.17B | |
+2.00% | 982M | |
+41.91% | 872M | |
+21.91% | 799M | |
+6.82% | 675M | |
+1.72% | 664M | |
+72.63% | 654M | |
-.--% | 600M |
- Stock Market
- Equities
- IVBT Stock
- News Innovation1 Biotech Inc.
- Innovation1 Biotech Inc. Announces the Resignation of Andrew Salzman as Chief Science Officer